Executive record

Naseem Zojwalla, M.D.

Chief Medical Officer at Olema Pharmaceuticals, Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:naseem-zojwalla-m-dVersion: public-0As of: 2026-09-30

Not yet claimed6 published Claims2 sources
  • Executive

Key Claims

Biography

Dr. Zojwalla has served as Chief Medical Officer since January 2022, previously serving as Vice President of Clinical Development at Turning Point Therapeutics and Peloton Therapeutics. She was previously an Assistant Clinical Professor of Medicine at Columbia University Medical Center and holds an M.D. from Temple University School of Medicine.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Executive career

  1. Current · dates not publishedChief Medical Officer · Olema Pharmaceuticals, Inc.
  2. 2026 to end not publishedExecutive title: Chief Medical Officer · Organization not publishedOLMA DEF 14A executive officers

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

2 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. OLMA DEF 14A executive officers

    sec filing · Source published: Apr 29, 2026 · Retrieved: May 5, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 5, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 5, 2026
    • Executive company: Executive at Olema Pharmaceuticals, Inc. · Claim reviewed: May 5, 2026
    • Executive title: Executive title: Chief Medical Officer · Claim reviewed: May 5, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 5, 2026

  2. Open source

    sec def 14a · Source published: Apr 29, 2026 · Retrieved: Sep 12, 2026

    Supports 1 claim
    • Professional Role: Chief Medical Officer at Olema Pharmaceuticals, Inc. · Claim reviewed: Sep 12, 2026